Sprachen

  1. Forschung
  2. Veröffentlichungen

Veröffentlichungen

Filter: Schlüsselwort is Echocardiography  [Alle Filter zurücksetzen]
2004
Urhausen A, Albers T, Kindermann W. "Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?" Heart. 2004;90(5):496-501.
Kindermann W, Urhausen A. "Left ventricular dimensions and function in strength athletes. Re: Hartgens F, Cheriex EC, Kuipers H. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med." Int J Sports Med. 2004;25(3):241-2; author reply 243-4.
Scharhag J, Urhausen A, Kindermann W. "Suggested new upper limit of physiologic cardiac hypertrophy determined in Japanese ultramarathon runners must be interpreted cautiously." J. Am. Coll. Cardiol.. 2004;44(2):470-1; author reply 471.
2005
Meyer T, Görge G, Schwaab B, et al. "An alternative approach for exercise prescription and efficacy testing in patients with chronic heart failure: a randomized controlled training study." Am. Heart J.. 2005;149(5):e1-7.
2006
Scharhag J, Urhausen A, Schneider G, et al. "Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes." Eur J Cardiovasc Prev Rehabil. 2006;13(3):388-97.
2008
George K, Shave R, Warburton D, Scharhag J, Whyte G. "Exercise and the heart: can you have too much of a good thing?" Med Sci Sports Exerc. 2008;40(8):1390-2.
2010
Thünenkötter T, Schmied C, Dvorák J, Kindermann W. "Benefits and limitations of cardiovascular pre-competition screening in international football." Clin Res Cardiol. 2010;99(1):29-35.
Scharhag J, Thünenkötter T, Urhausen A, Schneider G, Kindermann W. "Echocardiography of the right ventricle in athlete's heart and hearts of normal size compared to magnetic resonance imaging: which measurements should be applied in athletes?" Int J Sports Med. 2010;31(1):58-64.
2011
Karlowatz R-J, Scharhag J, Rahnenführer J, et al. "Polymorphisms in the IGF1 signalling pathway including the myostatin gene are associated with left ventricular mass in male athletes." Br J Sports Med. 2011;45(1):36-41.